User profiles for "author:Sang-Yoon Park"

Sang Yoon Park

- Verified email at mail.nih.gov - Cited by 1575

Sang Yoon Park

- Verified email at i2r.a-star.edu.sg - Cited by 1429

Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies

S Kang, HJ Yoo, JH Hwang, MC Lim, SS Seo… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: The validity of the sentinel lymph node (SLN) procedure for the assessment of
nodal status in patients with endometrial cancer is unclear. We aimed to assess the …

Adaptor protein complexes and intracellular transport

SY Park, X Guo - Bioscience reports, 2014 - portlandpress.com
The AP (adaptor protein) complexes are heterotetrameric protein complexes that mediate
intracellular membrane trafficking along endocytic and secretory transport pathways. There …

Recent trends in surface treatment technologies for airframe adhesive bonding processing: a review (1995–2008)

SY Park, WJ Choi, HS Choi, H Kwon… - The Journal of …, 2010 - Taylor & Francis
Proper surface treatment technologies are prerequisite for achieving long-term service
capability through the adhesive bonding process. However, the current surface treatment …

Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node …

HJ Choi, JW Roh, SS Seo, S Lee, JY Kim, SK Kim… - Cancer, 2006 - Wiley Online Library
BACKGROUND The objective of the current study was to determine the accuracy of
magnetic resonance imaging (MRI) and positron emission tomography/computed …

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200) …

E Pujade-Lauraine, K Fujiwara, JA Ledermann… - The lancet …, 2021 - thelancet.com
Background Most patients with ovarian cancer will relapse after receiving frontline platinum-
based chemotherapy and eventually develop platinum-resistant or platinum-refractory …

Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial

MC Lim, SJ Chang, B Park, HJ Yoo, CW Yoo… - JAMA …, 2022 - jamanetwork.com
Importance Ovarian cancer has the highest mortality rate among gynecologic malignant
tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal …

Quality of life and sexual problems in disease‐free survivors of cervical cancer compared with the general population

SY Park, DS Bae, JH Nam, CT Park… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. The purpose of this study was to identify problems related to long‐term
quality of life (QOL) and sexual function in cervical cancer survivors. METHODS. The authors …

[HTML][HTML] Secondary surgical cytoreduction for recurrent ovarian cancer

RL Coleman, NM Spirtos, D Enserro… - … England Journal of …, 2019 - Mass Medical Soc
Background Secondary surgical cytoreduction in women with platinum-sensitive, recurrent
epithelial ovarian, primary peritoneal, or fallopian-tube (“ovarian”) cancer is widely practiced …

NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions

WH Yang, SY Park, HW Nam, DH Kim… - Proceedings of the …, 2008 - National Acad Sciences
The transcription factor NFκB is activated by phosphorylation and acetylation and plays
important roles in inflammatory and immune responses in the cell. Additionally …

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm …

JW Youn, SY Hur, JW Woo, YM Kim, MC Lim… - The Lancet …, 2020 - thelancet.com
Background Survival outcomes for patients with recurrent or advanced cervical cancer are
poor. Pembrolizumab has been approved for the treatment of recurrent or metastatic cervical …